Selected Start-Ups (7/00)
Executive Summary
In Vivo summarizes the technologies of several recently founded companies: formed through the combination of Scriptgen Pharmaceuticals Inc. and key scientists and related assets of the EMBL, Scripps and UCSD, Anadys Pharmaceuticals Inc. will discover and develop new drugs to treat infectious diseases, including those that are resistant to current therapies. Astex Technology Ltd. will offer high throughput X-ray crystallography to provide rapid generation of protein crystal structures. Biosupplies.com has launched the first Internet marketplace for custom-built DNA oligonucleotides and peptides with technology that allows researchers to design products to their own specifications and then shop for them online. Friz Biochem GmbH was founded in August 1999 to develop a DNA biochip platform for the rapid detection of genetic information. Minerva Pharmaceuticals Inc. will develop diagnostic and therapeutic products that will allow human cancers to be diagnosed and treated at an early stage, before they become life threatening. Founded in November 1999, Motac Neuroscience Ltd. will offer technical expertise and state-of-the art facilities to support the drug discovery efforts of its strategic partners.